Compared with daily insulin glargine U100, combination therapy of icodec plus semaglutide improves glycated hemoglobin A1c (HbA1c) and is associated with reduced body weight and lower rates of clinically significant or severe hypoglycemic events in insuli... See more
Continuous glucose monitoring (CGM) threshold alerts modestly improve glycemic control, but adding predictive alerts provides no additional benefit, according to study results published in JAMA Network Open. The use of inpatient CGM is increasing, yet cle... See more
Continuous glucose monitoring (CGM) threshold alerts modestly improve glycemic control, but adding predictive alerts provides no additional benefit, according to study results published in JAMA Network Open. The use of inpatient CGM is increasing, yet cle... See more
Continuous glucose monitoring (CGM) threshold alerts modestly improve glycemic control, but adding predictive alerts provides no additional benefit, according to study results published in JAMA Network Open. The use of inpatient CGM is increasing, yet cle... See more
Continuous glucose monitoring (CGM) threshold alerts modestly improve glycemic control, but adding predictive alerts provides no additional benefit, according to study results published in JAMA Network Open. The use of inpatient CGM is increasing, yet cle... See more
